The AACR-Novocure Cancer Research Grants represent a joint effort to promote and support independent investigators who are currently conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage independent investigators to enter the TTFields research field.
These grants are intended to provide a deeper understanding of the mechanisms of action of this novel anti-cancer treatment modality and to accelerate the development of new treatment strategies to advance therapeutic options for cancer. The research proposed for funding may be basic or translational in nature; however, studies promoting the transition of in vitro work into in vivo systems, combination therapies involving TTFields, or translational projects bringing treatments involving TTFields into the clinic will be prioritized. The Inovitro® system (which will be provided by Novocure, if needed), must be included in the experimental design. Training on the use of Inovitro® system will be provided by Novocure, if needed. Note that inter-laboratory collaboration is encouraged, particularly for applicants new to TTFields research.
Deadline: June 30, 2025
Applicants must be AACR Active members who are independent investigators and have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
Current and past recipients of an AACR-Novocure Tumor Treating Fields Research Grants are not eligible to apply. Collaborators or other participants of an active AACR Novocure grant (at the time of application deadline) are also not eligible to apply. Current recipients of an AACR-Novocure Career Development Award for Tumor Treating Fields Research Grant may apply if their current grant ends and their final progress reports have been submitted and approved before the start of the grant term of this funding opportunity.
Current AACR grantees may apply only if their current grant ends before the start of the grant term of this funding opportunity (December 1, 2025). Also, the terms of their current grant must require that the final progress reports be approved by the AACR. Please contact the AACR’s Research and Grants Administration (RGA) for confirmation before applying.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible. Employees or subcontractors of a U.S. government entity or for‐profit private industry may serve as Collaborators, but no grant funds may be directed toward these individuals.
Each grant provides $350,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators, postdoctoral or clinical research fellows, graduate students and/or research assistants; research/laboratory supplies; equipment; travel; publication charges for manuscripts that pertain directly to the funded project; other research expenses; and indirect costs.